Page 5 - மூலோபாய வர்த்தகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மூலோபாய வர்த்தகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மூலோபாய வர்த்தகம் Today - Breaking & Trending Today

South Africa's Aspen could produce J&J COVID shots by end-March

South Africa s Aspen could produce J&J COVID shots by end-March
Reuters
7/01/2021
By Promit Mukherjee
JOHANNESBURG (Reuters) - Aspen Pharmacare could start production of Johnson & Johnson COVID-19 vaccines in South Africa by late March or early April if all approvals are in place, a senior company executive said.
All the vaccines produced will be exported to J&J and will be a part of its global supply inventory, Stavros Nicolaou, Group Senior Executive, Strategic Trade at Aspen, added.
We are going to receive a tech transfer to contract manufacture for them (J&J). Aspen has current capacity to manufacture up to 300 million doses of COVID vaccine, Nicolaou said in an interview with Reuters on Thursday, adding that these will be exported to J&J. ....

South Africa , South Africans , Aspen Pharmacare , Promit Mukherjee , Zweli Mkhize , Stavros Nicolaou , Alexander Smith , Group Senior , Serum Institute Of India , Group Senior Executive , Strategic Trade , Minister Zweli Mkhize , Serum Institute , Alexander Winning , ஆஸ்பென் மருந்தகம் , ஸ்ட்யாவ்ரோஸ் நிக்கொழாோஉ , அலெக்சாண்டர் ஸ்மித் , குழு மூத்தவர் , சீரம் நிறுவனம் ஆஃப் இந்தியா , குழு மூத்தவர் நிர்வாகி , மூலோபாய வர்த்தகம் , சீரம் நிறுவனம் , அலெக்சாண்டர் வென்றது ,

Highly possible that a Covid vaccine could be produced in SA

Highly possible that a Covid vaccine could be produced in SA
By Reuters
Share
JOHANNESBURG - Aspen Pharmacare could start production of Johnson & Johnson Covid-19 vaccines in South Africa by late March or early April if all approvals are in place, a senior company executive said.
All the vaccines produced will be exported to J&J and will be a part of its global supply inventory, Stavros Nicolaou, Group Senior Executive, Strategic Trade at Aspen, added.
We are going to receive a tech transfer to contract manufacture for them (J&J). Aspen has current capacity to manufacture up to 300 million doses of Covid vaccines, Nicolaou said in an interview with Reuters on Thursday, adding that these will be exported to J&J. ....

South Africa , South African , South Africans , Aspen Pharmacare , Zweli Mkhize , Stavros Nicolaou , Johnson Covid , Group Senior , Serum Institute Of India , Group Senior Executive , Strategic Trade , Minister Zweli Mkhize , Serum Institute , ஆஸ்பென் மருந்தகம் , ஸ்ட்யாவ்ரோஸ் நிக்கொழாோஉ , குழு மூத்தவர் , சீரம் நிறுவனம் ஆஃப் இந்தியா , குழு மூத்தவர் நிர்வாகி , மூலோபாய வர்த்தகம் , சீரம் நிறுவனம் ,

UPDATE 1-South Africa's Aspen could produce J&J COVID shots by end-March

UPDATE 1-South Africa s Aspen could produce J&J COVID shots by end-March
Reuters
1/7/2021
Govt says vaccine negotiation with J&J at advanced stage
Aspen to produce up to 300 million doses for J&J
J&J vaccine in final trial, results by end-January (Adds govt, J&J comment)
By Promit Mukherjee
JOHANNESBURG, Jan 7 (Reuters) - Aspen Pharmacare could start production of Johnson & Johnson COVID-19 vaccines in South Africa by late March or early April if all approvals are in place, a senior company executive said.
All the vaccines produced will be exported to J&J and will be a part of its global supply inventory, Stavros Nicolaou, Group Senior Executive, Strategic Trade at Aspen, added. ....

South Africa , South African , South Africans , Philippa Fletcher , Aspen Pharmacare , Promit Mukherjee , Zweli Mkhize , Stavros Nicolaou , Alexander Smith , Group Senior , Serum Institute Of India , Group Senior Executive , Strategic Trade , Minister Zweli Mkhize , Serum Institute , Alexander Winning , பிலிப்பா பிளெட்சர் , ஆஸ்பென் மருந்தகம் , ஸ்ட்யாவ்ரோஸ் நிக்கொழாோஉ , அலெக்சாண்டர் ஸ்மித் , குழு மூத்தவர் , சீரம் நிறுவனம் ஆஃப் இந்தியா , குழு மூத்தவர் நிர்வாகி , மூலோபாய வர்த்தகம் , சீரம் நிறுவனம் , அலெக்சாண்டர் வென்றது ,

Aspen could produce J&J COVID shots by end-March

Image: Supplied
Aspen Pharmacare could start production of Johnson & Johnson COVID-19 vaccines in South Africa by late March or early April if all approvals are in place, a senior company executive said.
All the vaccines produced will be exported to J&J and will be a part of its global supply inventory, Stavros Nicolaou, Group Senior Executive, Strategic Trade at Aspen, added.
“We are going to receive a tech transfer to contract manufacture for them (J&J)… Aspen has current capacity to manufacture up to 300 million doses of COVID vaccine,” Nicolaou said in an interview with Reuters on Thursday, adding that these will be exported to J&J. ....

South Africa , South Africans , Aspen Pharmacare , Zweli Mkhize , Stavros Nicolaou , Group Senior , Serum Institute Of India , Group Senior Executive , Strategic Trade , Minister Zweli Mkhize , Serum Institute , ஆஸ்பென் மருந்தகம் , ஸ்ட்யாவ்ரோஸ் நிக்கொழாோஉ , குழு மூத்தவர் , சீரம் நிறுவனம் ஆஃப் இந்தியா , குழு மூத்தவர் நிர்வாகி , மூலோபாய வர்த்தகம் , சீரம் நிறுவனம் ,

Highly possible a the Covid vaccine could be produced in SA

Highly possible a the Covid vaccine could be produced in SA
iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.

South Africa , South African , South Africans , Aspen Pharmacare , Zweli Mkhize , Stavros Nicolaou , Johnson Covid , Group Senior , Serum Institute Of India , Group Senior Executive , Strategic Trade , Minister Zweli Mkhize , Serum Institute , ஆஸ்பென் மருந்தகம் , ஸ்ட்யாவ்ரோஸ் நிக்கொழாோஉ , குழு மூத்தவர் , சீரம் நிறுவனம் ஆஃப் இந்தியா , குழு மூத்தவர் நிர்வாகி , மூலோபாய வர்த்தகம் , சீரம் நிறுவனம் ,